X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL

Acute lymphoblastic leukemia (ALL) represents the most frequent malignancy in children, and relapse/refractory (r/r) disease is difficult to treat, both in children and adults. In search for novel treatment options against r/r ALL, we studied inhibitor of apoptosis proteins (IAP) and Smac mimetics (...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlet, Michela, Schmelz, Karin, Vergalli, Jenny, Herold, Tobias, Senft, Daniela, Jurinovic, Vindi, Hoffmann, Thomas, Proba, Jutta, Weichert, Nina, Junghanß, Christian, Roth, Mareike, Eschenburg, Georg, Barz, Malwine, Henze, Günter, Eckert, Cornelia, Eggert, Angelika, Zuber, Johannes, Hundsdoerfer, Patrick, Jeremias, Irmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832863/
https://www.ncbi.nlm.nih.gov/pubmed/36416169
http://dx.doi.org/10.15252/emmm.202114557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832863/
https://www.ncbi.nlm.nih.gov/pubmed/36416169
http://dx.doi.org/10.15252/emmm.202114557

Ejemplares similares